Nafarelin nasal spray for egg maturation
Part of Women’s health & pregnancy clinical trials.
This trial tests a nasal spray (nafarelin) to help mature eggs before they are frozen for fertility preservation. It may be an option for women using a specific hormone protocol (PPOS) during their treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman having eggs frozen to preserve your fertility
- You are using a progesterone-based hormone protocol (PPOS) for your cycle
- Your body mass index (BMI) is between 18 and 30
- You are not allergic to nafarelin or similar drugs
- You do not have a pituitary tumor or hypopituitarism
- You have not had a poor reaction to a similar trigger drug before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two hormone protocols for ovarian stimulation in women having their first cycle—either to freeze eggs for fertility preservation or for IVF with genetic testing. The goal is to see which method leads to more usable eggs while being easier on the patient.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
This study compares two types of hormonal support—a GnRH agonist (given as a nasal spray) versus progesterone—after a frozen embryo transfer in a natural menstrual cycle. It aims to see which helps more women achieve pregnancy.
This trial tests whether giving a medication called a GnRH agonist during the luteal phase (the time after egg retrieval) can help with IVF success. It is for people who are using a specific medication protocol (recombinant FSH with an antagonist) and have certain hormone levels.
This study tests a different type of fertility medication to help women who had fewer than 9 eggs retrieved in a previous IVF cycle. It's designed for women between 18 and 40 with a specific hormone profile, and aims to improve egg collection results.
This trial tests how well and safely a new drug (Fang Le Shu) works compared to a standard drug (Guo Na Fen) for stimulating the ovaries to produce eggs for IVF. It may help women who have had trouble getting pregnant for at least a year.
Hear when a new Fertility Preservation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.